Portfolio Lab

Zimmer Biomet Holdings, Inc.

  • Stock
  • Ticker ZBH
  • ISIN US98956P1021
  • NYSE

Health care · Medical technology · USA

$101.10 −0.36%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Zimmer Biomet Holdings, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

ZBHGlobal equities (VT)

$10,000 grew to $11,079. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −52.1% in 05/2026, measured from the peak in 04/2021. The old peak has not been reached again yet.

1-year return
+14.7%
5-year return p.a.
−3.3%
10-year return p.a.
+1.0%
Volatility p.a.
25.8%
Largest decline
−52.1%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue2,0231,9092,0772,0012,2442,0872,1772,063
Gross profit1,4371,3591,4851,4421,4511,5111,5421,468
Operating income389292300351155373326308
EBITDA653547572635439643597590
Net income240182153231139238198192
Earnings per share1.190.910.771.160.711.221.031.00
Balance sheet
Total assets21,36522,18422,86523,48823,09222,72222,79823,539
Liabilities8,8899,78010,33110,72210,38610,04010,16510,813
Equity12,46812,39512,52512,75712,69812,67312,62412,716
Cash5261,3855571,293592424410400
Long-term debt5,3426,5766,7537,5136,9326,2956,2786,217
Cash flow
Operating cash flow506383378419517359448560
Capital expenditure-52-45-50-55-75-36-54-76
Free cash flow455338328364443323394484

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2019 at +45.4%, weakest 2021 at −17.0%. 4 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
4 Nov 2026$1.00
5 Aug 2026$1.03
1 May 2026$1.22
20 Feb 2026$0.71
5 Nov 2025$1.16
7 Aug 2025$0.77
5 May 2025$0.91
25 Feb 2025$1.19
30 Oct 2024$1.23
7 Aug 2024$1.18
2 May 2024$0.84
23 Feb 2024$2.00

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€17bn
Market cap in trading currency
$19.1bn
Enterprise value
$26.2bn
P/E
25.5
P/S
2.23
P/B
1.50
EV/Sales
3.06
EV/EBITDA
11.6
Earnings yield
3.9%
FCF yield
8.6%

Results (last four quarters)

Revenue
$8.57bn
Gross profit
$5.97bn
EBITDA
$2.27bn
Net income
$767m
Earnings per share
$3.96
Revenue per share
$45.29
Revenue growth
+3.1%
Earnings growth
−17.0%

Profitability

Gross margin
69.7%
Operating margin
13.6%
Net margin
9.0%
Return on equity
6.0%
Return on assets
3.3%

Balance sheet and cash flow

Cash
$400m
Cash per share
$2.11
Financial debt
$7.50bn
Debt/equity %
59
Current ratio
1.46
Book value per share
$67.19
Operating cash flow
$1.88bn
Free cash flow
$1.64bn

Dividend

Dividend yield
0.95%
Dividend (12 months)
$0.96
Yield (12 months)
0.95%
Payout ratio
24%
Ex-dividend date
30 Sep 2026

Shares and trading

Shares outstanding
189m
Volume
2.96m
Avg. volume 3 months
2.05m
Relative volume
1.4

Price and technicals

Price
$101.10
1 day
−0.4%
52-week high
$110.15
52-week low
$79.58
Distance to 52-week high
−8.2%
Distance to 52-week low
+27.0%
Distance to 50-day line
+4.8%
Distance to 200-day line
+8.8%
RSI (14)
51
Volatility 1M
52.5%

Performance

1 week
−2.0%
1 month
+2.3%
3 months
+0.1%
6 months
+18.2%
YTD
+12.4%
1 year
+13.0%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has ZBH performed since 11/2016?

$10,000 grew to $11,079 by 20 Nov 2026, which is +1.0% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is ZBH?

Volatility was 25.8% per year, measured on monthly returns. The largest decline from a peak was −52.1%, with the low in 05/2026.

How does ZBH compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, ZBH returned +1.0% at 25.8%. The correlation of monthly returns was 0.52; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Zimmer Biomet Holdings, Inc. (ZBH): Return and risk